Compensated dispensed diabetes medicines Netherlands 2014-2021

In 2021, a total of nearly 231 million euros was compensated and charged by Dutch pharmacies to the health insurance companies. Annual growth of diabetes sales in pharmacies was significant over the given period.

Compensated dispensed diabetes medicines and goods in the Netherlands from 2014 to 2021* (in euros)

Characteristic	Compensation in euros
2021	230,877,100
2020	232,586,600
2019	222,830,300
2018	215,634,300
2017	209,964,500
2016	208,691,700
2015	207,154,600
2014	203,535,700

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

April 2022

More information

Region

Netherlands

Survey time period

2014 to 2021

Supplementary notes

The compensation are the costs charged by pharmacies to the health insurance, excluding taxes. The compensation is on the basis of mutual agreements between the insurance companies and pharmacies and therefore can differ per pharmacy. Furthermore, the compensation is excluding the delivery tariff of the pharmacy.

* Concerning pharmaceutical goods that are prescribed as well as (outside of institutions like hospitals and nursing homes) provided and compensated on the basis of the health insurance law (ZVW).

Citation formats